Gilead Owed $68M In Counterfeit Case, Magistrate Judge Says
A New York federal magistrate judge has recommended awarding $68 million to biopharmaceutical company Gilead Sciences Inc. from a group of companies it accused of producing counterfeit HIV drugs that never...To view the full article, register now.
Already a subscriber? Click here to view full article